title: A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy.
abstract: A resolutive therapy for muscular dystrophies, a heterogeneous group of genetic diseases leading to muscular degeneration and in the severe forms to death, is still lacking. Since inflammation and defects in nitric oxide generation are recognized key pathogenic events in muscular dystrophy, we have analysed the effects of a derivative of ibuprofen, NCX 320, belonging to the class of cyclooxygenase inhibiting nitric oxide donator (CINOD), in the α-sarcoglycan null mice, a severe mouse model of dystrophy. NCX 320 was administered daily in the diet for 8months starting 1month from weaning. Muscle functional recovery was evaluated by free wheel and treadmill tests at 8months. Serum creatine kinase activity, as well as the number of diaphragm inflammatory infiltrates and necrotic fibres, was measured as indexes of skeletal muscle damage. Muscle regeneration was evaluated in diaphragm and tibialis anterior muscles, measuring the numbers of centronucleated fibres and of myogenic precursor cells. NCX 320 mitigated muscle damage, reducing significantly serum creatine kinase activity, the number of necrotic fibres and inflammatory infiltrates. Moreover, NCX 320 stimulated muscle regeneration increasing significantly the number of myogenic precursor cells and regenerating fibres. All these effects concurred in inducing a significant improvement of muscle function, as assessed by both free wheel and treadmill tests. These results describe the properties of a new compound incorporating nitric oxide donation together with anti-inflammatory properties, showing that it is effective in slowing muscle dystrophy progression long term. Of importance, this new compound deserves specific attention for its potential in the therapy of muscular dystrophy given that ibuprofen is well tolerated in paediatric patients and with a profile of safety that makes it suitable for chronic treatment such as the one required in muscular dystrophies.
authors: San Raffaele Scientific Institute, Division of Regenerative Medicine, Via Olgettina 58, 20132 Milan, Italy. sciorati.clara@hsr.it
authors: Clara
authors: C
authors: Sciorati
authors: Daniela
authors: D
authors: Miglietta
authors: Roberta
authors: R
authors: Buono
authors: Viviana
authors: V
authors: Pisa
authors: Dario
authors: D
authors: Cattaneo
authors: Emanuele
authors: E
authors: Azzoni
authors: Silvia
authors: S
authors: Brunelli
authors: Emilio
authors: E
authors: Clementi
references: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003725
references: 18254031
references: Inflamm Res. 2001 Dec;50(12):602-8
references: 11822786
references: Pharmacol Res. 2009 Feb;59(2):90-100
references: 19073262
references: Br J Pharmacol. 2010 Jul;160(6):1550-60
references: 20590643
references: Muscle Nerve. 2005 Dec;32(6):751-60
references: 16116642
references: Physiol Rev. 2001 Jan;81(1):209-237
references: 11152758
references: Cardiovasc Res. 2010 Jul 1;87(1):73-82
references: 20164117
references: Neurosci Lett. 2005 Jul 15;382(3):342-5
references: 15925116
references: Physiol Genomics. 2009 Apr 10;37(2):119-32
references: 19223608
references: J Cell Sci. 2006 Dec 15;119(Pt 24):5114-23
references: 17158915
references: Yakugaku Zasshi. 2005 Sep;125(9):733-7
references: 16141693
references: Am J Pathol. 2008 Jun;172(6):1509-19
references: 18458097
references: Neuromuscul Disord. 2001 Sep;11(6-7):517-24
references: 11525879
references: BMC Musculoskelet Disord. 2010 Jul 11;11:157
references: 20618995
references: Nitric Oxide. 2009 Nov-Dec;21(3-4):157-63
references: 19682596
references: Lancet. 2002 Feb 23;359(9307):687-95
references: 11879882
references: Anal Chem. 2000 Sep 1;72(17):4064-72
references: 10994966
references: Trends Pharmacol Sci. 2009 Mar;30(3):112-7
references: 19230986
references: Int J Clin Pract Suppl. 2003 Apr;(135):9-12
references: 12723740
references: J Cell Biol. 1998 Sep 21;142(6):1461-71
references: 9744877
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 25;780(2):341-8
references: 12401360
references: Science. 2003 Feb 7;299(5608):896-9
references: 12574632
references: J Clin Invest. 2010 Dec;120(12):4366-74
references: 21060153
references: Br J Pharmacol. 2009 Sep;158(2):569-79
references: 19594750
references: Pharmacol Res. 2010 Sep;62(3):243-8
references: 20451614
references: Apoptosis. 2003 Dec;8(6):573-8
references: 14574063
references: Neurobiol Dis. 2009 Nov;36(2):252-8
references: 19632329
references: Neurotherapeutics. 2008 Oct;5(4):583-91
references: 19019310
references: Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):264-9
references: 17182743
references: Neuromuscul Disord. 2001 Sep;11(6-7):556-64
references: 11525885
references: Exp Gerontol. 2008 Dec;43(12):1094-101
references: 18824083
references: Pharmacol Res. 2010 Apr;61(4):265-8
references: 19913098
references: Expert Opin Investig Drugs. 2007 Jan;16(1):33-43
references: 17155852
references: Pediatr Neurol. 1996 Jan;14(1):7-12
references: 8652023
references: Pharmacol Res. 2009 Jul;60(1):1-17
references: 19427580
references: Mol Biol Cell. 2000 May;11(5):1859-74
references: 10793157
references: Pharmacol Res. 2009 May;59(5):285-9
references: 19416627
references: Eur J Pharmacol. 2007 Sep 10;570(1-3):115-24
references: 17632098
references: FASEB J. 2009 Jul;23(7):2131-41
references: 19264835
references: Neurobiol Dis. 2005 Oct;20(1):123-30
references: 16137573
references: Exp Cell Res. 2010 Nov 1;316(18):3100-8
references: 20546725
references: Eur J Pain. 2000;4(2):195-209
references: 10957700
references: Muscle Nerve. 1981 May-Jun;4(3):204-13
references: 7242559
references: Pharmacol Res. 2009 Oct;60(4):221-8
references: 19539763
references: J Cell Biol. 2006 Jan 16;172(2):233-44
references: 16401724
references: Hum Mol Genet. 2002 Feb 1;11(3):263-72
references: 11823445
references: Br J Clin Pharmacol. 2001 Oct;52(4):387-98
references: 11678782
references: J Cell Biol. 2001 Oct 1;155(1):123-31
references: 11581289
references: Mol Pharm. 2009 May-Jun;6(3):895-904
references: 19317416
references: Cell. 1995 Sep 8;82(5):743-52
references: 7545544